ABSTRACT
Bone metastasis of prostate cancer is very common in the clinical practice. The bone metastasis-associated skeletal complications such as cancer-induced bone pain, pathological bone fractures and metastatic epidural spinal cord compression seriously affect the quality of life, reduce the overall survival of patients, and increase the financial burdens at home. Therefore, only the effective systemic therapy combined with the anti-bone metastasis treatment can reduce the occurrence of these complications, and prolong the overall survival of patients. At present, there are various treatments for the prostate cancer patients with bone metastasis, but no uniform standard to evaluate the therapeutic efficacy for the patients with simple bone metastasis of prostate cancer. In order to select the best treatment more conveniently, evaluate the therapeutic effect accurately and adjust the therapeutic regimen in time, this article reviews the current treatment methods, the latest study results and the mainstream evaluation criteria for bone metastasis of prostate cancer.